Nelson Institute of Environmental Medicine, New York University School of Medicine, NY 10987, USA.
Crit Rev Toxicol. 2013 Jul;43(6):493-514. doi: 10.3109/10408444.2013.794769.
DNA methylation plays an intricate role in the regulation of gene expression and events that compromise the integrity of the methylome may potentially contribute to disease development. DNA methylation is a reversible and regulatory modification that elicits a cascade of events leading to chromatin condensation and gene silencing. In general, normal cells are characterized by gene-specific hypomethylation and global hypermethylation, while cancer cells portray a reverse profile to this norm. The unique methylome displayed in cancer cells is induced after exposure to carcinogenic metals such as nickel, arsenic, cadmium, and chromium (VI). These metals alter the DNA methylation profile by provoking both hyper- and hypo-methylation events. The metal-stimulated deviations to the methylome are possible mechanisms for metal-induced carcinogenesis and may provide potential biomarkers for cancer detection. Development of therapies based on the cancer methylome requires further research including human studies that supply results with larger impact and higher human relevance.
DNA 甲基化在基因表达的调控中起着复杂的作用,而破坏甲基组完整性的事件可能会导致疾病的发生。DNA 甲基化是一种可逆的调节修饰,它引发了一系列事件,导致染色质凝聚和基因沉默。一般来说,正常细胞的特点是基因特异性低甲基化和全基因组高甲基化,而癌细胞则呈现出相反的特征。在接触致癌金属如镍、砷、镉和六价铬等之后,癌细胞中会表现出独特的甲基组。这些金属通过引发超甲基化和低甲基化事件来改变 DNA 甲基化谱。金属刺激对甲基组的偏离是金属诱导致癌的可能机制,并可能为癌症检测提供潜在的生物标志物。基于癌症甲基组的治疗方法的发展需要进一步的研究,包括提供更大影响和更高人类相关性的人类研究。